top of page

Key Risks

Full transparency and a high level of integrity is how we operate, and seek the same in our investors.

What you should know

  • Construction timeline
    While the facility is scheduled for opening in Q1 or Q2 2024, there may be delays in construction which may or may not be significant.
  • Natural disaster
    Modelling by the Indonesian Climate Agency (CAMCG) shows a risk of a tsunami in Bali in the next 100 years. This is a low probability in the near term, but the impact would obviously be severe.
  • SEZ conditions diluted/changed
    Corporate tax concessions, international staff working permits and Japanese regulatory cover are all important SEZ conditions contributing to a viable project. Any reduction in these conditions due to reduced political backing weakens the investment case. This is deemed to be low risk prior to 2024 general elections, given President Joko Widodo’s public backing of the success of the SEZ.
  • Geopolitical
    The reliance on international clients requires a benign geopolitical environment. This includes, for example, international perceptions of local laws such as the recently introduced law against sex outside of marriage, applied to tourists as well as Indonesians. The risk of such things as future global pandemics and China’s role in the region is ever present and can be mitigated through maintaining a domestic client base to complement the international clients.
  • Insurance and Medical Catastrophe
    Is a risk with any innovative medical technology. Insurances will need to sought and all care taken. The risk is considered to be low given the Japanese history but the impact could be high.
  • Concentration Risk
    The investment is exposed to a single asset (via an investment in the securities of Simplr).
  • Potential Loss of Investment
    No guarantee that the investment will be successful, and investors may lose all or some of their investment.
  • Market Risk
    Potential for cost of building supplies and labour to fluctuate or for unfavourable market conditions to influence the success of the investment if there are no tourists to attend the regenerative facility.
  • Uninsured Losses
    Simplr or the proposed Indonesian SPV may not have sufficient insurance to cover certain risks.
  • Investment Controls
    Controls around investment into Indonesia or obtaining returns out of Indonesia may change.
  • Foreign currency and exchange risk
    The risk that the value of the Indonesian Rupiah changes, which could impact the value of the return on investment.
  • Banking risk
    The banking and other financial systems of many emerging markets are not well developed or well regulated. Delays in transfers by banks may result as may liquidity crises and other problems arising as a result of the under-capitalisation of the banking sector as a whole. If a general banking crisis occurs in Indonesia, it is anticipated to likely have a material adverse effect on the investment.
  • General Warning
    The risks itemised above do not represent an exhaustive list. Other risks include the continued solvency of Simplr, forecast returns not being met, tax risks, force majeure and potential breaches of the JV and other agreements. There may be risks that at the time of writing this IM could not reasonably have been foreseen. Units to be issued carry no guarantee with respect to the payment of distributions, returns of capital or the market value of those securities.
Facility Capabilities

More
Info

Background figures for the Regenerative Medicine Market, and impact areas in Medical Tourism.

​

See details

Male Scientist

Simplr International has brought together leading Japanese Regenerative Health Care specialists, Indonesian health consulting experts, support from both Indonesian and Australian Governments, and a team of leading industry specialists.
​

Learn more

Key Info

The Sanur SEZ is designed to attract 4–8% of the Indonesian outbound medical tourism market (80–60 thousand people) by 2030 in addition to in-bound medical tourists from other countries.

 

Learn more

Facility Image 2.png

As a leading regenerative medicine specialist facility, the aim of the clinic will be to provide state-of-the-art stem cell therapy for cancer treatment, with services supported by the world-class oncology center at Bali International Hospital, also to be located in the Special Economic Zone.

 

Learn more

Summary of the project aspects and investment opportunity.

​

See details

bottom of page